GLP- 1(T) 10mg, 20mg , 30mg, 40mg
Price range: $ 170.00 through $ 180.00
GLP-1(R) 10MG & 20MG
Price range: $ 170.00 through $ 175.00
Recently View Products
CJC1295 no DAC – 2mg & 5mg
Price range: $ 39.00 through $ 49.00
Select options
This product has multiple variants. The options may be chosen on the product page
Modified GRF (CJC-1295 No DAC) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.
Kisspeptin – 5mg &10mg
Price range: $ 70.00 through $ 75.00
Select options
This product has multiple variants. The options may be chosen on the product page
KPV – 5mg & 10mg
Price range: $ 70.00 through $ 75.00
Select options
This product has multiple variants. The options may be chosen on the product page
KPV is a potent anti-inflammatory peptide that has shown promise in a number of disease conditions. The most active research is in the treatment of inflammatory bowel disease where the peptide has showed substantial promise. Research in wound healing also reveals that KPV and other alpha-MSH derivatives may offer a host of benefits that speed wound healing, reduce infection, fight inflammation, and lead to better cosmetic results. KPV and similar peptides could become mainstays not just in wound healing, but in scar reduction following surgery.
LL-37 – 5mg
$ 95.00
SS-31 – 10mg & 20mg
Price range: $ 100.00 through $ 150.00
Select options
This product has multiple variants. The options may be chosen on the product page
Tesamorelin – 5mg & 10mg
Price range: $ 70.00 through $ 75.00
Select options
This product has multiple variants. The options may be chosen on the product page
Tesamorelin, is a syntheitic peptide consiting of 44 amino acids. It is a growth-hormone-releasing hormone (GHRH) analogue researched for the treatment of HIV-associated lipodystrophy (dysfunctional, toxic fat deposition). It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment, and the reduction visceral fat. This peptide has been found to reduce adiposity by nearly 20% in this population. Research suggests that tesamorelin is approximately 4 times more effective in reducing adiposity than all of the other available therapies combined .